[RNAZ] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[RNAZ] TransCode Therapeutics, Inc.
Announcement Date
15-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- 73.86%
YoY- -38.95%
Quarter Report
RNAZ's Result
RNAZ's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 753 0 0 0 0 0 0 -
PBT -4,088 -5,300 -4,342 -4,817 -5,134 -4,290 -4,671 -8.48%
Tax -0 27 789 -5 13,275 655 -36 -
NP -4,088 -5,300 -4,342 -4,812 -18,409 -4,290 -4,635 -8.01%
Tax Rate - - - - - - - -
Total Cost 4,841 5,300 4,342 4,812 18,409 4,290 4,635 2.93%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin -542.73 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS -22.83 -67.95 -135.68 -267.34 -1,134.84 -264.45 -289.70 -81.53%
EPS Diluted -22.83 -67.15 -131.61 -267.34 -1,134.84 -264.45 -285.73 -81.36%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.